Phase II Trial of Amsacrine Plus Intermediate-dose Ara-C (IDAC) with or without Etoposide as Salvage Therapy for Refractory or Relapsed Acute Leukemia
Year: 2005
Type: article
Study design: Clinical Trial
DOI: 10.1093/jjco/hyi149
Institution: Kyungpook National University Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2140191908
